Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TMC Life Sciences BhdXKLS:0101 61 Earnings Yield (Joel Greenblatt) % is 3.40% as of Mar. 2026, which is 7% above its 10-year median of 3.17. GuruFocus rates XKLS:0101 with a GF Score™ of 61/100 and a GF Value™ of RM0.63 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 684 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks worse than 51.02% on this metric.
TMC Life Sciences Bhd's Enterprise Value for the quarter that ended in Mar. 2026 was RM874.1 Mil.
TMC Life Sciences Bhd's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was RM29.7 Mil. TMC Life Sciences Bhd's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 3.40%.
The historical rank and industry rank for TMC Life Sciences Bhd's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
XKLS:0101'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 0.86 Med: 3.17 Max: 6.68
Current: 3.51
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of TMC Life Sciences Bhd was 6.68%. The lowest was 0.86%. And the median was 3.17%.
XKLS:0101's Earnings Yield (Joel Greenblatt) % is ranked worse than 51.02% of 684
companies
in the Healthcare Providers & Services industry
Industry Median: 3.71
vs XKLS:0101: 3.51
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. TMC Life Sciences Bhd's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 11.77%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
TMC Life Sciences Bhd (XKLS:0101) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
TMC Life Sciences Bhd Earnings Yield (Joel Greenblatt) % Related Terms
TMC Life Sciences Bhd Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for TMC Life Sciences Bhd's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TMC Life Sciences Bhd Earnings Yield (Joel Greenblatt) % Chart
For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMC Life Sciences Bhd Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where TMC Life Sciences Bhd's Earnings Yield (Joel Greenblatt) % falls into.
TMC Life Sciences Bhd Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
TMC Life Sciences Bhds Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Jun. 2025 is calculated as
TMC Life Sciences Bhd's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM29.7 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 3.40% mean?
TMC Life Sciences Bhd (XKLS:0101) has a Earnings Yield (Joel Greenblatt) % of 3.40% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on TMC Life Sciences Bhd and its competitors. This is near median its historical median of 3.17. Over the past decade, TMC Life Sciences Bhd's Earnings Yield (Joel Greenblatt) % has ranged from 0.86 to 6.68. According to the industry distribution chart, TMC Life Sciences Bhd ranks #349 out of 684 companies in the Healthcare Providers & Services industry, placing it in the top 51%.
Is TMC Life Sciences Bhd's Earnings Yield (Joel Greenblatt) % too high?
TMC Life Sciences Bhd's current Earnings Yield (Joel Greenblatt) % of 3.40% is near median its 10-year median of 3.17. Over the past 10 years, this metric has ranged from a low of 0.86 to a high of 6.68. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.71. TMC Life Sciences Bhd's value of 3.40% is 8.4% below this industry median. Based on the distribution chart, TMC Life Sciences Bhd ranks #349 out of 684 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, TMC Life Sciences Bhd has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's Earnings Yield (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #349 out of 684 companies for Earnings Yield (Joel Greenblatt) %. This places TMC Life Sciences Bhd in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.71. TMC Life Sciences Bhd's value of 3.40% is 8.4% below this benchmark. Historically, TMC Life Sciences Bhd's own Earnings Yield (Joel Greenblatt) % has ranged from 0.86 to 6.68 over the past decade. While the company's 10-year median is 3.17 vs. the industry median of 3.71, TMC Life Sciences Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.71, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TMC Life Sciences Bhd's current Earnings Yield (Joel Greenblatt) % of 3.40% is 8.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on TMC Life Sciences Bhd and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current Earnings Yield (Joel Greenblatt) % is 3.40%, which is near median its own 10-year median of 3.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.63, compared to a current price of RM0.47 — trading 26.2% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 3.40%, which is near median its 10-year median of 3.17 and 8.4% below the Healthcare Providers & Services industry median of 3.71. TMC Life Sciences Bhd's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current Earnings Yield (Joel Greenblatt) % is 3.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?
Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued.
The current stock price of RM0.47 is trading 26.2% below its estimated GF Value™ of RM0.63.
GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0101:
Earnings Yield (Joel Greenblatt) %: 3.40% (near median its 10-year median of 3.17)
GF Value™: RM0.63 vs. price of RM0.47 (26.2% below fair value)
Industry Position: 8.4% below the Healthcare Providers & Services median (#349 of 684)
No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
61GF Score
Get the complete analysis for XKLS:0101
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0101 has been successfully added to your 
